Optison™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP)

 

Customer Support

 
Current customers with inquiries related to orders, price, payment, supply chain, or other questions, please contact our Customer Services team
 

Medical Affairs

 
For peer-to-peer scientific exchange or clinical applications related to our products, please contact our Medical Affairs team
 

Sales

 
New customers with inquiries about Optison, obtaining a quote, pricing information, purchase conditions, and supply chain information, please contact our Sales team
Request sales contact

Our Sales team will respond to requests within 48 hours
 

Pharmacovigilance

 
To report patient adverse events, side effects, reactions, or any unwanted medical occurrence, please contact our Pharmacovigilance team
(800) 654-0118 (option 2, option 1)
Monday to Friday 8 am – 5 pm ET

gpv.drugsafety@gehealthcare.com
 

Market Access/Reimbursement

 
For questions or support related to reimbursement, coding, and coverage for Optison, please contact our Market Access team
(800) 767-6664
Monday to Friday 8 am – 6 pm ET

Optison Reimbursement Guide
 

Optison Return Policy

 

JB06755US July 2024